News

Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...
Ultrasound-detected bursitis and higher baseline BMI are associated with the development of musculoskeletal symptoms in ...
A new study published in the journal of Photodermatology, Photoimmunology and Photomedicine showed that people with psoriasis ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited data and urging tailored approaches.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 10, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) announced enrolling the ...
Researchers have identified in a new study that increased serum 25-hydroxyvitamin D (25(OH)D) is linked with lower risks of ...
US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared ...
“It highlights that psoriasis is not just a skin condition, but a systemic disease that can impact multiple organs and systems.” Positive Lifestyle Changes Can Go a Long Way in Keeping ...
This excerpt from ‘Glowing Skin and Gorgeous Hair’ explains how our skin is a window into our emotional and mental health ...
Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic ...